JP Morgan Chase’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
1,088,514
+250,775
+30% +$4.15M ﹤0.01% 2146
2025
Q4
$11M Buy
837,739
+663,578
+381% +$7.83M ﹤0.01% 2595
2025
Q3
$1.25M Buy
174,161
+134,764
+342% +$7.02M ﹤0.01% 4426
2025
Q2
$1.86M Buy
39,397
+38,556
+4,585% +$1.57M ﹤0.01% 3971
2025
Q1
$32.9K Sell
841
-409
-33% -$17.6K ﹤0.01% 6012
2024
Q4
$67.7K Buy
1,250
+14
+1% +$715 ﹤0.01% 5903
2024
Q3
$62.3K Sell
1,236
-16,472
-93% -$772K ﹤0.01% 5912
2024
Q2
$779K Buy
17,708
+17,703
+354,060% +$750K ﹤0.01% 4427
2024
Q1
$251 Sell
5
-1,443
-100% -$78.3K ﹤0.01% 6787
2023
Q4
$87.4K Sell
1,448
-274,150
-99% -$14.1M ﹤0.01% 5801
2023
Q3
$15.7M Sell
275,598
-22,580
-8% -$1.25M ﹤0.01% 1872
2023
Q2
$15.2M Sell
298,178
-5,044
-2% -$136K ﹤0.01% 1919
2023
Q1
$6.49M Buy
303,222
+258,378
+576% +$4.34M ﹤0.01% 2621
2022
Q4
$471K Buy
+44,844
New +$399K ﹤0.01% 4566

Other funds holding MLTX